Restrictive Versus Liberal Transfusion in Symptomatic Coronary Artery Disease and Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

医学 狼牙棒 心肌梗塞 随机对照试验 内科学 冠状动脉疾病 优势比 荟萃分析 血运重建 心力衰竭 置信区间 不利影响 心脏病学 传统PCI
作者
Sahib T Singh,Udaya S. Tantry,Kevin P. Bliden,Paul A. Gurbel,Eliano Pio Navarese,Aakash Garg
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:31 (6): e677-e682 被引量:1
标识
DOI:10.1097/mjt.0000000000001762
摘要

BACKGROUND: In patients with coronary artery disease (CAD) and/or myocardial infarction (MI), anemia is associated with an increased risk of adverse cardiovascular (CV) outcomes. Transfusion goals in such patients remain unclear. STUDY QUESTION: A meta-analysis of the available randomized controlled trials (RCTs) was conducted comparing restrictive and liberal transfusion strategies in patients with symptomatic CAD/MI. DATA SOURCES: Multiple online databases including Cochrane, Pubmed, Embase, and MEDLINE were searched for RCTs. STUDY DESIGN: End points of interest were major adverse CV events (MACEs), MI, all-cause death, CV death, revascularization, heart failure (HF), and infection. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random-effects model. RESULTS: A total of 5 RCTs with 4518 patients-2258 in the restrictive transfusion group and 2260 in the liberal transfusion group-were included. The mean age was 72 years, and 59% of patients were men. At 30 days, MACE and MI were similar in the 2 transfusion groups. However, at the longest available follow-up, the restrictive strategy was associated with increased risks of MACE (OR 1.18, 95% CI, 1.02-1.37; P = 0.03) and MI (1.27, 95% CI, 1.02-1.58; P = 0.04), along with the higher trend of all-cause death (1.21, 95% CI, 1.00-1.46; P = 0.05) as compared with liberal transfusion. The 2 groups had comparable rates of CV death, revascularization, HF, and infection. CONCLUSIONS: Liberal transfusion strategy may be associated with improved CV outcomes among patients with symptomatic CAD/MI as compared with a restrictive transfusion strategy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT的应助被ccc采纳,获得10
刚刚
星辰大海的应助被dipa采纳,获得10
1秒前
小蘑菇的应助被rilin采纳,获得50
1秒前
Jasper的应助被orrange采纳,获得10
2秒前
TCG完成签到,获得积分20
2秒前
陶军辉发布了新的文献求助10
2秒前
TUTU发布了新的文献求助10
2秒前
3秒前
3秒前
希望天下0贩的0的应助被李琦采纳,获得10
4秒前
烟花的应助被笨笨晓蓝采纳,获得10
4秒前
流泪猫猫头完成签到,获得积分10
5秒前
追逐123完成签到 ,获得积分10
5秒前
鲤鱼鑫磊发布了新的文献求助10
5秒前
5秒前
123发布了新的文献求助10
6秒前
爆米花的应助被TCG采纳,获得10
7秒前
7秒前
施宛儿完成签到 ,获得积分10
7秒前
7秒前
不爱喝酒的应助被冲冲冲采纳,获得10
7秒前
王海钰发布了新的文献求助10
8秒前
清一完成签到,获得积分10
8秒前
8秒前
唔西迪西完成签到,获得积分10
8秒前
Sheep完成签到,获得积分10
9秒前
小郭发布了新的文献求助10
9秒前
曹可凡完成签到,获得积分10
10秒前
懵懂的惜海完成签到,获得积分10
10秒前
段宏高完成签到,获得积分10
10秒前
赘婿的应助被好家伙采纳,获得10
11秒前
dududu完成签到 ,获得积分10
11秒前
12秒前
ygm完成签到,获得积分10
13秒前
zy发布了新的文献求助10
13秒前
倾慕发布了新的文献求助10
13秒前
段宏高发布了新的文献求助10
13秒前
Orange的应助被李琦采纳,获得10
15秒前
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187412
求助须知:如何正确求助?哪些是违规求助? 9575481
关于积分的说明 21841736
捐赠科研通 7785184
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481846